Skip to main content

Want a detailed portfolio tracker?

Immutep (IMMP) P/E (2012 - 2026)

Immutep (IMMP) P/E from Apr 17, 2012 to Jul 20, 2026. The TTM Immutep (IMMP) P/E is -0.68. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immutep (IMMP)

YearP/EChange
2026-0.68-85.75%
2025-4.79+0.60%
2024-4.76+7.63%
2023-4.42+60.57%
2022-2.75-46.26%
2021-5.13+16.38%
2020-4.40+11.24%
2019-3.96+5.10%
2018-3.77-47.16%
2017-7.13+269.63%
2016-1.93+5.17%
2015-1.83-55.57%
2014-4.13-19.40%
2013-5.12-57.39%
2012-12.02N/A

Comparison Immutep (IMMP) P/E with competitors

Immutep (IMMP) P/E is -0.68.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.25%
NBYStablecoin Development Corp0.00-100.63%
ENLVEnlivex Ltd0.07-110.96%
FGENFibroGen Inc0.24-135.17%
CHRSCoherus Biosciences Inc0.85-224.31%
FBIOFortress Biotech Inc0.95-239.03%
ORMPOramed Pharmaceuticals Inc1.50-320.19%
AGENAgenus Inc3.01-540.90%
INVAInnoviva Inc3.15-562.06%
VXRTVaxart Inc3.55-620.03%
CRMDCorMedix Inc3.63-631.56%
CVACCureVac N.V.4.45-751.28%
GLPGGalapagos NV4.86-811.81%
SRPTSarepta Therapeutics Inc4.88-815.21%
ABEOAbeona Therapeutics Inc5.39-889.25%
ABUSArbutus Biopharma Corp5.60-919.74%
ZVRAZevra Therapeutics Inc5.89-962.46%
SPROSpero Therapeutics Inc6.23-1012.45%
CGENCompugen Ltd6.31-1024.97%
RIGLRigel Pharmaceuticals6.87-1106.74%
SLXNSilexion Therapeutics Corp7.30-1168.86%
OMEROmeros Corporation9.26-1456.38%
AUPHAurinia Pharmaceuticals Inc9.58-1504.17%
PLXProtalix BioTherapeutics Inc10.89-1695.50%
ACADAcadia Pharmaceuticals Inc11.73-1818.20%
TBPHTheravance Biopharma Inc12.26-1896.37%
ADMAAdma Biologics Inc12.42-1919.23%
HRMYHarmony Biosciences Holdings Inc13.82-2124.62%
SABSSAB Biotherapeutics Inc14.14-2170.92%
NAGENiagen Bioscience Inc14.82-2270.82%
INCYIncyte Corp15.82-2417.97%
REGNRegeneron Pharmaceuticals Inc15.86-2422.96%
PBYIPuma Biotechnology Inc17.32-2636.71%
CPRXCatalyst Pharmaceuticals Inc17.44-2654.82%
EXELExelixis Inc17.54-2669.28%
TGTXTG Therapeutics Inc18.97-2878.48%
MDXGMimedx Group Inc20.55-3110.90%
XOMAXOMA Royalty Corp22.87-3451.18%
ARGXArgen X SE24.30-3659.70%
CTMXCytomX Therapeutics Inc24.82-3736.33%
XOMAOXOMA Royalty Corp25.34-3813.06%
HALOHalozyme Therapeutics Inc25.62-3853.91%
XOMAPXOMA Royalty Corp25.67-3860.71%
VRTXVertex Pharmaceuticals Inc27.99-4201.27%
RPRXRoyalty Pharma plc - Class A28.69-4302.77%
SLNOSoleno Therapeutics Inc29.02-4350.79%
ASNDAscendis Pharma A/S30.09-4507.58%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5654.17%
APLSApellis Pharmaceuticals Inc39.02-5816.67%
BMRNBiomarin Pharmaceutical Inc42.21-6284.10%
KRYSKrystal Biotech Inc45.34-6742.89%
ONCBeiGene Ltd69.54-10287.79%
PHARPharming Group N.V.75.03-11091.37%
TECHBio-Techne Corp101.96-15037.07%
VCELVericel Corp109.92-16203.66%
ALNYAlnylam Pharmaceuticals Inc117.96-17382.09%
GMABGenmab140.29-20652.83%
TLXTelix Pharmaceuticals Ltd162.15-23855.66%
CORTCorcept Therapeutics Inc212.86-31283.99%